Indian J Med Microbiol Close
 

Figure 1: The proportion of patients who reached the primary efficacy and secondary virological endpoint. (a) Proportion of patients with HIV-1 RNA <50 copies/ml. (b) Proportion of patients with HIV-1 RNA <400 copies/ml

Figure 1: The proportion of patients who reached the primary efficacy and secondary virological endpoint. (a) Proportion of patients with HIV-1 RNA <50 copies/ml. (b) Proportion of patients with HIV-1 RNA <400 copies/ml